These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 211087)

  • 21. Biological activities of crystalline pertussigen from Bordetella pertussis.
    Munoz JJ; Arai H; Bergman RK; Sadowski PL
    Infect Immun; 1981 Sep; 33(3):820-6. PubMed ID: 6269999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Niridazole suppression of experimental allergic encephalomyelitis in Lewis rats.
    Paterson PY; Harvey JM; Webster LT
    J Immunol; 1977 Jun; 118(6):2151-4. PubMed ID: 301156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between aquaporin-4 expression and blood-brain and spinal cord barrier permeability following experimental autoimmune encephalomyelitis in the rat.
    Huang XN; Wang WZ; Fu J; Wang HB
    Anat Rec (Hoboken); 2011 Jan; 294(1):46-54. PubMed ID: 21157915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic relapsing experimental allergic encephalomyelitis. Studies in vascular permeability changes.
    Kristensson K; Wiśniewski HM
    Acta Neuropathol; 1977 Aug; 39(3):189-94. PubMed ID: 906801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin immunoreactivity in spinal cord axons and terminals of rodents with experimental allergic encephalomyelitis.
    White SR; Vyas D; Bieger D
    Neuroscience; 1985 Nov; 16(3):701-9. PubMed ID: 3912676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of experimental allergic encephalomyelitis by alpha 2-macroglobulin.
    Hunter N; Weston KM; Bowern NA
    Immunology; 1991 May; 73(1):58-63. PubMed ID: 1710603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A quantitative assay for experimental allergic encephalomyelitis in the rat based on permeability of spinal cords to 125I-human gamma-globulin.
    Stohl W; Kaplan MS; Gonatas NK
    J Immunol; 1979 Mar; 122(3):920-5. PubMed ID: 87421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system.
    Linthicum DS; Munoz JJ; Blaskett A
    Cell Immunol; 1982 Nov; 73(2):299-310. PubMed ID: 6891621
    [No Abstract]   [Full Text] [Related]  

  • 29. Cerebral vascular permeability and cellular infiltration in experimental allergic encephalomyelitis.
    Leibowitz S; Kennedy L
    Immunology; 1972 May; 22(5):859-69. PubMed ID: 5021707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cell vaccination in monoclonal antibody-induced hyperacute experimental allergic encephalomyelitis.
    Schluesener HJ; Meyermann R
    J Neuroimmunol; 1989 Oct; 24(3):233-8. PubMed ID: 2478583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of amphetamine and cocaine on the development of acute experimental allergic encephalomyelitis in Lewis rats.
    Núñez MJ; Balboa J; Rey-Méndez M; Brenlla J; González-Peteiro M; Rodrigo E; Freire-Garabal M
    Hum Exp Toxicol; 2007 Aug; 26(8):637-43. PubMed ID: 17884951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allergic encephalomyelitis in rats - toxicity assay for pertussis vaccines.
    Ronneberger H; Zwisler O
    Arch Toxicol Suppl; 1980; 4():179-83. PubMed ID: 6933900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of spinal cord-induced experimental allergic encephalomyelitis in the Lewis rat with liposomes presenting central nervous system antigens.
    Stein CS; St Louis J; Gilbert JJ; Strejan GH
    J Neuroimmunol; 1990 Jul; 28(2):119-30. PubMed ID: 1694533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CENTRAL NERVOUS SYSTEM TISSUE: IS IT AN IMMUNOLOGIC ADJUVANT?
    LEVINE S; WENK EJ; KIES MW; ALVORD EC
    Neurology; 1965 Jun; 15():560-4. PubMed ID: 14312779
    [No Abstract]   [Full Text] [Related]  

  • 35. Concordance and localization of maximal vascular permeability change and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis.
    Koh CS; Gausas J; Paterson PY
    J Neuroimmunol; 1992 May; 38(1-2):85-93. PubMed ID: 1577954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of acute autoimmune encephalomyelitis in mice: factors regulating the effector phase of the disease.
    Linthicum DS
    Immunobiology; 1982 Aug; 162(3):211-20. PubMed ID: 6290379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain and spinal cord levels of histamine in Lewis rats with acute experimental autoimmune encephalomyelitis.
    Orr EL; Stanley NC
    J Neurochem; 1989 Jul; 53(1):111-8. PubMed ID: 2786054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen.
    Munoz JJ; Bernard CC; Mackay IR
    Cell Immunol; 1984 Jan; 83(1):92-100. PubMed ID: 6607126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental allergic encephalomyelitis in Lewis rats bearing avian sarcoma virus-induced brain tumors.
    Strauss MM; Bigner SH; Bigner DD
    J Neuroimmunol; 1982 Jun; 2(3-4):283-94. PubMed ID: 6282929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic relapsing experimental allergic encephalomyelitis in Lewis rats as a model of multiple sclerosis].
    Zaprianova E; Deleva D; Bakalska M; Filchev N
    Morfologiia; 1997; 112(6):25-8. PubMed ID: 9606089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.